Evaluation of dynamic thiol/disulfide redox state in community-acquired pneumonia

References

1. ↵
   1. Aston SJ

   (2017) Pneumonia in the developing world: Characteristic features and approach to management. Respirology 22:1276–1287.

   OpenUrl
2. ↵
   1. Aliberti S,
   2. Morlacchi LC,
   3. Faverio P,
   4. Fernandez-Botran R,
   5. Cosentini R,
   6. Mantero M,
   7. et al.

   (2016) Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study. Pneumonia (Nathan) 23:8.

   OpenUrl
3. ↵
   1. Shaddock EJ

   (2016) How and when to use common biomarkers in community-acquired pneumonia. Pneumonia (Nathan) 28:17.

   OpenUrl
4. ↵
   1. Anevlavis S,
   2. Bouros D

   (2010) Community acquired bacterial pneumonia. Expert Opin Pharmacother 11:361–374.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Biswas SK,
   2. Rahman I

   (2009) Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Mol Aspects Med 30:60–76.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Erel O,
   2. Neselioglu S

   (2014) A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 47:326–332.

   OpenUrlCrossRefPubMed
7. ↵
   1. Atmaca G

   (2004) Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 45:776–788.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Biswas S,
   2. Chida AS,
   3. Rahman I

   (2006) Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 71:551–564.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Circu ML,
   2. Aw TY

   (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749–762.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Farah R,
    2. Makhoul N

    (2011) Usefulness of various inflammatory markers to differentiate pulmonary edema from pneumonia. Isr Med Assoc J 13:225–229.

    OpenUrlPubMed
11. ↵
    1. Ozkan Y,
    2. Ozkan E,
    3. Simşek B

    (2002) Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol 82:269–277.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Go YM,
    2. Jones DP

    (2011) Cysteine/cystine redox signaling in cardiovascular disease. Free Radic Biol Med 50:495–509.

    OpenUrlCrossRefPubMed
13. ↵
    1. Turell L,
    2. Radi R,
    3. Alvarez B

    (2013) The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 65:244–253.

    OpenUrlCrossRefPubMed
14. ↵
    1. Castillo RL,
    2. Carrasco RA,
    3. Alvarez PI,
    4. Ruiz M,
    5. Luchsinger V,
    6. Zunino E,
    7. et al.

    (2013) Relationship between severity of adult community-acquired pneumonia and impairment of the antioxidant defense system. Biol Res 46:207–213.

    OpenUrl
15. ↵
    1. Duflo F,
    2. Debon R,
    3. Goudable J,
    4. Chassard D,
    5. Allaouchiche B

    (2002) Alveolar and serum oxidative stress in ventilator-associated pneumonia. Br J Anaesth 89:231–236.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Trefler S,
    2. Rodríguez A,
    3. Martín-Loeches I,
    4. Sanchez V,
    5. Marín J,
    6. Llauradó M,
    7. et al.

    (2014) Oxidative stress in immunocompetent patients with severe community-acquired pneumonia. A pilot study. Med Intensiva 38:73–82.

    OpenUrl
17. ↵
    1. Katsoulis K,
    2. Kontakiotis T,
    3. Baltopoulos G,
    4. Kotsovili A,
    5. Legakis IN

    (2005) Total antioxidant status and severity of community-acquired pneumonia: are they correlated? Respiration 72:381–387.

    OpenUrlCrossRefPubMed
18. ↵
    1. Muravlyova L,
    2. Molotov-Luchankiy V,
    3. Bakirova R,
    4. Klyuyev D,
    5. Demidchik L,
    6. Lee V

    (2016) Characteristic of the oxidative stress in blood of patients in dependence of community-acquired pneumonia severity. Open Access Maced J Med Sci 4:122–127.

    OpenUrl
19. ↵
    1. Rahman I,
    2. MacNee W

    (2000) Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16:534–554.

    OpenUrlAbstract/FREE Full Text
20. ↵
    1. Crapo JD

    (2003) Oxidative stress as an initiator of cytokine release and cell damage. Eur Respir J Suppl 44:4–6.

    OpenUrl
21. ↵
    1. Nowak D,
    2. Zieba M,
    3. Zawiasa D,
    4. Rozniecki J,
    5. Król M

    (1996) Changes of serum concentration of lipid peroxidation products in patients with pneumonia. Monaldi Arch Chest Dis 51:188–193.

    OpenUrlPubMed
22. ↵
    1. Curbelo J,
    2. Luquero Bueno S,
    3. Galván-Román JM,
    4. Ortega-Gómez M,
    5. Rajas O,
    6. Fernández-Jiménez G,
    7. et al.

    (2017) Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio. Plos One 12:e0173947.

    OpenUrlPubMed
23. ↵
    1. Mokhtari V,
    2. Afsharian P,
    3. Shahhoseini M,
    4. Kalantar SM,
    5. Moini A

    (2017) A review on various uses of N-acetyl cysteine. Cell J 19:11–17.

    OpenUrlPubMed